Literature DB >> 8708079

Correction method for end-tidal xenon concentration in CBF measurements with xenon-enhanced CT.

S Sase1.   

Abstract

PURPOSE: The goal of this work is to show how variations in respiratory rate and tidal volume affect calculated cerebral blood flow (CBF) values on xenon-enhanced CT. In xenon-enhanced CT examination, the patient often takes shallow and rapid breaths. Thus, it is less likely that end-tidal xenon concentration reflects arterial xenon concentration, and appropriate correction measures should be taken for the end-distal respiratory data to obtain reliable CBF values.
METHOD: Preliminary breathing tests were performed using a lung phantom to determine the influence of respiratory volume and rate on end-tidal xenon concentration. Two xenon-enhanced CT studies were conducted of a healthy person with completely different respiratory manners between two studies. One was deep and slow respiration. The other was shallow and rapid respiration.
RESULTS: The lung phantom results prove that deep and slow respiration is essential for the end-tidal method. The results of xenon-enhanced CT studies of the same person show that the direct use of end-tidal data for shallow and rapid respiration leads to CBF values much lower than the actual values.
CONCLUSION: Differences in respiratory rate and tidal volume during xenon inhalation can significantly affect calculated CBF values on xenon-enhanced CT. With use of the correction methods described herein, these effects can be minimized. We have derived the end-tidal correction method on the assumption that a person's CBF values should be kept unchanged regardless of different respiratory manners.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8708079     DOI: 10.1097/00004728-199607000-00034

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  3 in total

1.  Xenon-inhalation computed tomography for noninvasive quantitative measurement of tissue blood flow in pancreatic tumor.

Authors:  Masaru Kubota; Takamichi Murakami; Hiroaki Nagano; Hidetoshi Eguchi; Shigeru Marubashi; Shogo Kobayashi; Hiroshi Wada; Masahiro Tanemura; Keizo Dono; Shoji Nakamori; Masato Sakon; Morito Monden; Masaki Mori; Yuichiro Doki
Journal:  Dig Dis Sci       Date:  2011-09-28       Impact factor: 3.199

2.  Quantitative tissue blood flow measurement of the liver parenchyma: comparison between xenon CT and perfusion CT.

Authors:  Kazuhiko Hashimoto; Takamichi Murakami; Keizo Dono; Masatoshi Hori; Tonsok Kim; Masayuki Kudo; Shigeru Marubashi; Atsushi Miyamoto; Yutaka Takeda; Hiroaki Nagano; Koji Umeshita; Hironobu Nakamura; Morito Monden
Journal:  Dig Dis Sci       Date:  2007-02-23       Impact factor: 3.199

3.  Noninvasive quantitative measurement of tissue blood flow in hepatocellular carcinoma using xenon-enhanced computed tomography.

Authors:  Junzo Shimizu; Hiroshi Oka; Keizo Dono; Masato Sakon; Manabu Takamura; Takamichi Murakami; Shouho Hayashi; Hiroaki Nagano; Shoji Nakamori; Koji Umeshita; Shigeru Sase; Mitsukazu Gotoh; Kenichi Wakasa; Hironobu Nakamura; Morito Monden
Journal:  Dig Dis Sci       Date:  2003-08       Impact factor: 3.199

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.